Menu Close

Karolinska Institutet

Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all.

As a university, KI is Sweden’s single largest centre of medical academic research and offers the country’s widest range of medical courses and programmes.

Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.

Karolinska Institutet was founded by King Karl XIII in 1810 as an “academy for the training of skilled army surgeons”. Today, Karolinska Institutet is a modern medical university and one of the foremost in the world.

With our close relationship to the clinical milieu, a well established infrastructure and a stable financial situation, Karolinska Institutet has excellent prerequisites for sustaining high quality research and education.


Displaying 1 - 20 of 73 articles

Les médicaments antirétroviraux pourraient diminuer le risque de sclérose en plaques ou atténuer les symptômes de la maladie, selon une nouvelle étude.

Les thérapies anti-VIH pourraient être efficaces contre la sclérose en plaques

Les personnes – et notamment les femmes – infectées par le VIH et suivant une thérapie antirétrovirale présentent un très réduit de développer une sclérose en plaques par rapport à la population générale.
A newborn baby holds a father’s finger. Getty Images

Baby deaths in Tanzania: being born in a city no longer increases their chances of survival

Urban populations are diverse, and certain neighbourhoods or subgroups may be disproportionately affected by poor birth outcomes.


More Authors